TOPRA is pleased to announce its new awards to recognize excellent regulatory practice and professionalism in individuals, teams, and organizations both within TOPRA and in the wider Regulatory Affairs community.
Nominations are now being accepted for the TOPRA Awards until May 24, 2010. To nominate your colleague or team, visit www.regulatoryaffairsawards.org.
Awards will be presented at the Gala Dinner at the 2010 Annual Symposium, which TOPRA is organizing in conjunction with MHRA. The ceremony will take place on October 5, 2010 in the grand Ballroom at the Hilton Park Lane, London.
Nominations are being received for five awards categories:
Inspiration: Recognizes role models and mentors
Horizon: Recognizes the significant achievements of newcomers to regulatory affairs
Innovation: Recognizes the importance of new ideas and processes in regulatory affairs
Support: Recognizes the significant role that supporting organizations can offer to regulatory affairs teams
Achievement: Recognizes a lifetime of achievement in regulatory affairs
Key Timelines
The following are the main time-points between now and the Awards Ceremony:
• The Awards will be open for entries from the week of 8 March 2010
• The closing date for entries will be the week of 24 May 2010
• Judges will receive the information on the entries by 7 June 2010
• The judging process is expected to finish in the week of 19 July 2010
• The shortlist will be announced in early August
• The winners will be announced at the Awards ceremony on 5 October 2010.
Contact: Email awards@topra.org or call +44 (0) 20 7510 2560 for more information.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Beyond the Molecule: How Human-Centered Design Unlocks AI's Promise in Pharma
June 23rd 2025How human-centered AI that is focused on customer, user, and employee experience can drive real transformation in clinical trials and beyond by aligning intelligent technologies with the people who use them.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.